Interaction between Aβ and Tau in the Pathogenesis of Alzheimer’s Disease

Cited by (685)

Items 501–600 of 685

1. Vaccination strategies in neurodegenerative proteinopathies
   Chunhao Tao, Deming Zhao, Lifeng Yang · 2026 · Ageing Research Reviews
2. Spatiotemporal characterization of Alzheimer disease pathology in living human brain tissue
   Aram Aslanyan, Soumya Mukherjee, Eleanor M. Moncur, Alicja Szadziewska, Yingxin He, Przemysław Radosław Kac, Reid A. Coyle, Elena Camporesi, Chihiro Sato, Nupur Ghoshal et al. · 2026 · Nature Communications
3. Interaction between Aβ and tau on reversion and conversion in mild cognitive impairment patients: After 2-year follow-up
   Jinzhi Tang, Qiuping Chen, Zhenfa Fu, Yuqun Liang, Guohua Xu, Huan Zhou, Bingjie He · 2024 · Heliyon
4. Presenilin deficiency enhances tau phosphorylation and its secretion
   Yang Sun, Sadequl Islam, Yuan Gao, Tomohisa Nakamura, Taisuke Tomita, Makoto Michikawa, Kun Zou · 2024 · Journal of Neurochemistry
5. Phenyl salicylate induces neurotoxicity and early Alzheimer's disease-like symptoms through ndrg1-regulated myelin damage, increasing bace1 in zebrafish
   Siyu Liu, Xinjia Li, Shouqing Jiao, Yuanteng Zheng, Lijie Xia, Yanier Núñez-Figueredo, Kechun Liu, Meng Jin · 2025 · The Science of The Total Environment
6. Dynamics and role of covalently-closed circular RNAs in Alzheimer's disease: A review of experimental and bioinformatics studies
   Nikta Zafarjafarzadeh, Elham Feridouni, Sudabe Sobhani-Moghaddam, Javad Amini, Samaneh Mollazadeh, Reza Ataei, Hamed Tabatabaei Ghomi, Cordian Beyer, Nima Sanadgol · 2025 · Neurobiology of Aging
7. The Importance of Vaccines in Preventing Impending Alzheimer’s Epidemic
   Siddhant Tripathi, Yashika Sharma, Dileep Kumar · 2025 · Reviews on Recent Clinical Trials
8. Plasticity and Co-Factor-Dependent Structural Changes in the RecA Nucleoprotein Filament Studied by Small-Angle X-Ray Scattering (SAXS) Measurements and Molecular Modeling
   Satomi Inaba‐Inoue, Afra Sabei, Anne-Elisabeth Molza, Mara Goff Prentiss, Tsutomu Mikawa, Hiroshi Sekiguchi, Chantal Prévost, Masayuki Takahashi · 2025 · Molecules
9. Editorial: Data-driven clinical biosignatures and treatment for neurodegenerative diseases
   Nizhuan Wang, Lei Chen, Wei Kong, Chung Y. Hsu, I‐Shiang Tzeng · 2023 · Frontiers in Neuroscience
10. Evaluating Combined Neurotoxicity of Amyloid Beta and Tau Oligomers in Alzheimer’s Disease: A New Criterion
    Andrey V. Kuznetsov · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
11. Linking Aβ and tau in the amyloid cascade through the intersection of their proteostasis networks
    Christine Maria Lim, John Hardy, Michele Vendruscolo · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
12. Tau conveys intrinsic hyperactivity of VTA dopamine neurons but an inability to sustain burst firing
    William M. Kennedy, Eva Troyano‐Rodriguez, Matthew H. Higgs, Harris E. Blankenship, Anu Korukonda, David Weinshenker, Heather C. Rice, Michael J. Beckstead · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
13. Using intracerebral microdialysis to probe the efficacy of repurposed drugs in Alzheimer’s disease pathology
    Christiana Bjorkli, Mary Elizabeth Hemler, Joshua B. Julian, Axel Sandvig, Ioanna Sandvig · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
14. To Explore the Mechanism of Alzheimer’s Disease Based on Brain-Gut Axis Theory
    奕玮 聂 · 2023 · Hans Journal of Biomedicine
15. Picroside II ameliorates Aβ-induced memory deficit by enhancing autophagy in mice
    Zhaolun Li, Maoju Wang, Yan He, Xiuyu Shi, Qiuyun Tian, Yepeng Fan, Fengming Ren, Zhifang Dong, Yehong Du · 2023 · Research Square
16. Exploring the Relationship between Cellular Senescence Markers and Aging-Related Diseases
    怡 罗 · 2023 · Advances in Clinical Medicine
17. Research Progress of Microglia in the Intervention Effect of Alzheimer's Disease
    Tianying Fang, Caiping Han, Qingli Song, Yaning Hao, Wei Yuan, Meng Yu, Lin Zhang · 2023 · Clinical Medicine Research
18. Neuronal Expression of Human Amyloid-β and Tau Drives Global Phenotypic and Multi-Omic Changes in C. elegans
    Angelina Holcom, Matías Fuentealba, Renuka Sivapatham, Christina D. King, Hadley Osman, Anna Foulger, Dipa Bhaumik, Birgit Schilling, David Furman, Julie Kay Andersen et al. · 2023 · SSRN Electronic Journal
19. Involvement of the cellular prion protein in seeding and spreading of sarkosyl-derived fractions of Alzheimer’s disease in Prnp mutant mice and in the P301S transgenic tauopathy mice model
    Julia Sala‐Jarque, Vanessa Gil, Pol Andrés‐Benito, Laia Lidón, Renato Eduardo Yanac-Huertas, Clara F. López-León, Félix Hernández, Jesús Ávila, José Luis Lanciego, Jordi Soriano et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
20. Research Progress of Chemical Synthesis Drugs and Biotechnology Drugs for Alzheimer’s Disease
    学权 陈 · 2024 · Open Journal of Natural Science
21. Interplay between Glypican-1, Amyloid-B and Tau Phosphorylation in Human Neural Stem Cells
    Fang Cheng, Lars‐Âke Fransson, Katrin Mani · 2024 · SSRN Electronic Journal
22. Analysis of genes associated with Alzheimer's disease and endoplasmic reticulum stress
    Ziyu Liu, Fei Li · 2024 · Research Square
23. Alzheimer’s disease as a form of in situ diabetes: A systematic review and meta-analysis of therapeutic approaches using intranasal insulin treatment
    Luís Jesuíno de Oliveira Andrade, Gabriela Correia Matos de Oliveira, Luís Matos de Oliveira · 2024 · medRxiv
24. The Role of Microglia and NLRP3 Inflammasome in Perioperative Neurocognitive Disorders
    Jing Sun, Chuanjun Li, Xiaohong Du, Yong Chen · 2024 · SSRN Electronic Journal
25. Toxicity Concerns Associated with the Radiopharmaceuticals for the Diagnosis of Alzheimer’s Disease
    Shristy Verma, Rishabha Malviya, Sathvik Belagodu Sridhar · 2024 · Central Nervous System Agents in Medicinal Chemistry
26. Alzheimer’s Disease and Diabetes Mellitus: Molecular Links
    Dildar Konukoğlu · 2024
27. Systems genetic dissection of Alzheimer’s disease brain gene expression networks
    Pinghan Zhao, Omar El Fadel, Anh Le, Carl Grant Mangleburg, Justin S. Dhindsa, Timothy Wu, Jinghan Zhao, Meichen Huang, Bismark Kojo Amoh, Aditi Sai Marella et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
28. Multiplex antimicrobial activities of the self-assembled amphiphilic polypeptide β nanofiber KF-5 against vaginal pathogens
    Ling Fang, Tiancheng Yang, Haojue Wang, Jun Cao · 2024 · Biology Direct
29. Global amyloid burden enhances network efficiency of tau propagation in the brain
    Meagan V. Lauber, Matteo Bellitti, Krish Kapadia, Varuna H. Jasodanand, Rhoda Au, Vijaya B. Kolachalama · 2024 · Journal of Alzheimer s Disease
30. The Role of Endoplasmic Reticulum Stress in Alzheimer's Disease: Molecular Mechanisms and Viral Hypotheses
    Yilong Zhou · 2025 · Theoretical and Natural Science
31. The calcium channel blocker Cav2.1 combined with amyloid beta monoclonal antibodies may reduce the occurrence of ARIA-E
    Dinghao An, Xiaotong Li, Yang Y. Xu · 2025 · Medical Hypotheses
32. Associations of late‐life blood pressure with CERAD , Braak , and Thal : Findings from the National Alzheimer's coordinating center neuropathology dataset
    Mo‐Kyung Sin, N. Maritza Dowling, Jeffrey M. Roseman, Ali Ahmed, EDWARD Y. ZAMRINI · 2025 · Neuropathology
33. Utilizing machine learning algorithms to identify biomarkers associated with Alzheimer's disease and ferroptosis-related genes
    Di Wang, Chunsheng Lin, Gang Liu, Xin Wang, Shengwang Han, Zengxin Han · 2025 · Technology and Health Care
34. Intracellular anionic substances cause tau liquid-liquid phase separation
    Kazuki Muguruma, Tetsuya Takahashi, Yuichiro Tagane, Keyoumu Nazere, Naoyuki Hara, Masahiro Nakamori, Yu Yamazaki, Hiroyuki Morino, Hirofumi Maruyama · 2025 · Biochemical and Biophysical Research Communications
35. The Therapeutic Role of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease: A Comprehensive Review
    Yunqing Lai · 2025 · Advances in Engineering Technology Research
36. High fat and high cholesterol diet induced cognitive impairment in GSDMD knockout mice via the compensatory activation of apoptosis pathway
    Ruitong Liu, Guiping Wang, Kuiying Gu, Tongtong Ma, Zhilong He, Li‐Qiang Qin, Zhongxiao Wan · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
37. Extracellular Vesicles and Purinergic Signaling in Alzheimer’s Disease—Joining Forces for Novel Therapeutic Approach
    Julita Lewandowska, Jakub Majewski, Katarzyna Roszek · 2025 · Brain Sciences
38. Microtubule-associated protein 4 forms aggregates consisting of helical filaments
    Shuto Miura, Eisuke Ishibashi, Takuto Nakamichi, Koji Uwai, Masahiro Kuragano, Kiyotaka Tokuraku · 2025 · Biochemistry and Biophysics Reports
39. β-Amyloid Pathways in Alzheimer's Disease: Mechanisms and Therapeutic Targets
    Sudha Bansal, Monu Yadav, Priyanka Bisht, Divyanshi Bansal, Shiva Tushir, Dev Rathore · 2025 · CNS & Neurological Disorders - Drug Targets
40. Nucleotide-Binding Oligomerization Domain-Like Receptor 3 Inflammatory Corpuscles: Pathogenesis and Targeted Therapy of Alzheimer’s Disease
    文丽 李 · 2025 · Advances in Clinical Medicine
41. Altered redox regulatory mechanisms in neurodegeneration
    Asim K. Duttaroy, Atala Bihari Jena · 2025 · Elsevier eBooks
42. Mini Review: How circular RNAs participate in neuro-degeneration
    Sima Biswas, Angshuman Bagchi · 2025 · Neuroscience Letters
43. Aging and Neurodegeneration
    Gaurav Gupta, Raihan Siddique, Riya Thapa, Asif Ahmad Bhat, Md Sadique Hussain, Thakur Gurjeet Singh, Sachin Kumar Singh, Saurabh Gupta, Pran Kishore Deb, Moayad Al Shahwan · 2025 · Springer eBooks
44. Research Review of the Mechanism of IL-17 in the Treatment of Alzheimer’s Disease
    燕琴 焦 · 2025 · Nursing Science
45. Infusion of blood from young and old mice modulates amyloid pathology
    Matías Pizarro, Ruben Gomez‐Gutierrez, Ariel Caviedes, Catalina Valdes, Ute Woehlbier, Cristian Vargas, Mauricio Hernández, Claudia A. Duran-Aniotz, Rodrigo Morales · 2025 · Aging
46. The Role of T Cells in Alzheimer's Disease
    Yu‐Hsuan Lin, Hongfei Zhao, Dandan Meng, Min Wang · 2025 · Critical Reviews in Immunology
47. Amygdala subregional atrophy across ATN-defined Mild Cognitive Impairment subgroups
    Qianqian Yuan, Darui Zheng, Wenzhang Qi, Xuhong Liang, Yiming Ruan, Yue Tang, Chen Xue, Chaoyong Xiao · 2026 · Frontiers in Neuroscience
48. Effectiveness of Insulin-Induced umbilical cord stem cells on Seladin-1/APP/GFAP expression in rat hippocampal CA1/CA3 regions following chronic hypoxia
    Gholamreza Hassanzadeh, Soheil Ashouri, Reza Kargar, Atefeh Shamosi, Simin Mahakizadeh · 2025 · Journal of Molecular Histology
49. Aggregation Characteristics of Tau Phosphorylated by Various Kinases as Observed by Quantum Dot Fluorescence Imaging
    Eisuke Ishibashi, K. Araya, Kota Nakamura, Keiya Shimamori, Koji Uwai, Masahiro Kuragano, Kiyotaka Tokuraku · 2025 · International Journal of Molecular Sciences
50. Nutraceuticals intervention in Alzheimer's disease: From farm to pharma
    P M Chaithra, B S Rakshith, S. Logesh, Kanthesh Maheshwarappa Basalingappa, T.S. Gopenath, Hung‐Ming Chang, George L. Perry, Sandeep Kumar Singh · 2025 · Journal of Alzheimer s Disease
51. Peptidomics of urinary biomarkers for Alzheimer’s disease
    Xu Fang, BingJia CUI, Xiaoyu Hong, Yong Wang · 2025 · Scientia Sinica Vitae
52. Predicted molecules followed by experimental validation for protecting human neurons from oxidative stress–induced cytotoxicity
    Xuyu Yang, Joo‐Youn Lee, Farbod A. Moghadam, Joseph P. Steiner, Soo‐Kyung Kim, Neha Ganjur, Adrian J. de Almenara, Brian M. Stoltz, Y. Peng Loh, William A. Goddard · 2025 · Proceedings of the National Academy of Sciences
53. Proteomic Insights Into the Pathogenesis of Intracerebral Hemorrhage: The Role of Blend Sign in Hematoma Expansion
    Hang Hang, Shanpeng Liu, Likun Wang, Linshan Zhang, Cuiying Liu, Baohui Xu, Heng Zhao, Guofeng Wu · 2025 · PROTEOMICS - CLINICAL APPLICATIONS
54. Antibodies targeting amyloid-β and Tau oligomers in Alzheimer’s disease
    Subashchandrabose Chinnathambi, Nagaraj Rangappa, Madhura Chandrashekar · 2025 · Advances in protein chemistry and structural biology
55. The Icelandic mutation APPA673T on amyloid-β plaque burden in the 5xFAD Alzheimer model
    Anne Anschuetz, Renny Listyono, Thomas Vorley, Bettina Platt, Charles R. Harrington, Gernot Riedel, K. Schwab · 2025 · bioRxiv
56. NMN alleviates cognitive impairment in Alzheimer's disease by regulating the gut microbiota through the Nrf2/HO-1 pathway
    Zhenyang Zang, Feng Chen, Lidan Gao, Qiulian Tang, Wang Luo, Yuxian Lin, Yingcong Yu · 2025 · Research Square
57. Dietary Polyphenols and the Aging Brain: Mechanistic Insights into Alzheimer’s Disease Prevention
    Prachi Patel, Ritu Khosla, Meenakshi Garg, Poonam Khare, Navkiran Kaur · 2025 · Nutritional neurosciences
58. Tau-Cytoskeleton and their interaction with other neurodegenerative proteins
    Surajita Sahu, Nagaraj Rangappa, Subashchandrabose Chinnathambi, Monalisa Mishra · 2025 · Advances in protein chemistry and structural biology
59. Molecular pathways underlying amyloid precursor protein–mediated regulation of adult-born neurons
    Hai-Dong Hu, Huidong Li, Yu Chen, Jianwen Zhou, Jian Chen, Qihong Tang, Xiaoshan Chen, Jinxiang Jiang, Mengyao Sun, Dongjing Jia et al. · 2025 · Neural Regeneration Research
60. Chemokine receptor CX3CR1 modulates microglial activity through Tau and amyloid-β interactions in Alzheimer’s disease
    Vaishnavi Ananathanarayana, Riddhi Upadhyay, Gouri H. Illanad, Deena Krishnan, Neha P. Bochageri, Murugan Sevanan, Zabin Bagewadi, R. Sivasamy, Subashchandrabose Chinnathambi · 2025 · Advances in immunology
61. Molecular chaperones as therapeutic gatekeepers in Alzheimer’s disease: Intersections with Tau aggregation, amyloid burden, and neuroinflammation
    Yukti, Anushka Sharma, Sarthak Dhar, Rupal Ojha, Vijay Kumar Prajapati · 2025 · Advances in protein chemistry and structural biology
62. Transforming anti-Alzheimer’s therapy by targeting endogenous receptorrial system through ligand-conjugated nanoformulations
    Madhuri Gawai, Neha T. Nistane, Amol Tatode, Mohammad Qutub, Milind Janrao Umekar, Tanvi Premchandani, Jayshree Taksande · 2025 · Ageing Research Reviews
63. Methyl eugenol as a multitarget-directed ligand for Alzheimer disease: A promising lead for drug design
    Natarajan Aiswarya, Chandran Remya, Krishnan Sajitha, Rakhi Rajan, Damodaran Madhavi Vasudevan, Kalarickal Vijayan Dileep · 2025 · ASPET Discovery
64. White Matter Tract Vulnerability to Amyloid Pathology on the Alzheimer’s Disease Continuum
    Bramsh Q. Chandio, Talia M. Nir, Julio E. Villalón‐Reina, Sophia I. Thomopoulos, Yixue Feng, Robert I. Reid, Clifford R. Jack, Michael Walter Weiner, Eleftherios Garyfallidis, Neda Jahanshad et al. · 2025 · International Symposium on Medical Information Processing and Analysis (SIPAIM)
65. Additional file 2 of Danggui Shaoyao San and disassembled prescription: neuroprotective effects via AMPK/mTOR-mediated autophagy in mice
    Xiaoqing Cheng, Dai, Yuqiong, Shang, Baoling, Zhang, Shuting, Lin, Liting, 吴庆光, Zhan, Ruoting, Shengqing Li, Liu, Sijun · 2024 · Figshare
66. Additional file 1 of Danggui Shaoyao San and disassembled prescription: neuroprotective effects via AMPK/mTOR-mediated autophagy in mice
    Xiaoqing Cheng, Dai, Yuqiong, Shang, Baoling, Zhang, Shuting, Lin, Liting, 吴庆光, Zhan, Ruoting, Shengqing Li, Liu, Sijun · 2024 · Figshare
67. Functional Disability and MMPs in Alzheimer’s Disease
    Nevra Alkanlı, Süleyman Serdar Alkanlı, Arzu Ay · 2025 · Springer eBooks
68. An investigation of Mukia maderaspatana (L.) M. Roem neuroprotective properties using the human neuroblastoma cell line SHSY-5Y: An in-vitro approach
    Kiruthiga Natarajan, Rajkuberan Chandrasekaran, John Joseph, Kalaiselvi Aasaithambi, Sakthivel Singaravel, Selvakumari Palani · 2025 · South African Journal of Botany
69. Biosimilars: Antibody and nanobody-based therapeutic approaches towards protein misfolding diseases
    Subashchandrabose Chinnathambi, Nagaraj Rangappa · 2025 · Advances in protein chemistry and structural biology
70. Tracking Neural Deterioration in proNGF-Overexpressing Mice: Hippocampal Serotonergic Dysfunction and Synaptic Loss Drive Neurodegeneration
    Nicole A. Bell, Ali S. Imami, Mahathi Srivatsan, Noah Jiang, Anya Musalgavkar, Ali Ridi, Robert E. McCullumsmith · 2025 · Translation The University of Toledo Journal of Medical Sciences
71. Computational Identification of Potent Multitarget Natural Ligands for Alzheimer’s Disease Therapeutics
    Nadia Sharif, Ayesha Bibi, Rakhshinda Sadiq, Iffat Ullah, Abdul Rauf, Muhammad Tayyab Arshad, Shahid Bashir, Hafsa Zamir, Sawaira Gull, Taqwa Anwar et al. · 2025 · Scientifica
72. Targeting NLRP3 inflammasome-driven neuroinflammation in Alzheimer’s disease
    Yanhua Wang, Hua Li · 2025 · Asia-Pacific Journal of Pharmacotherapy & Toxicology
73. Dementia and Diet: How Nutrients Can Influence Cognitive Decline
    Priyanka Sonkar, Mohd. Saif, Amit Sonkar · 2026 · Springer eBooks
74. Unraveling the molecular links: Alzheimer's disease-induced mechanisms of memory impairment: A narrative review
    Yousef Baghcheghi, Fateme Razazpour, Mola Mohammadi, Habibeh Mashayekhi‐Sardoo, Mahdiyeh Hedayati‐Moghadam · 2026 · Journal of Alzheimer s Disease Reports
75. Chronic Aerobic Exercise Alleviates Amyloid-induced Capillary Dysfunction
    Alfredo Cárdenas‐Rivera, Eda K. Erdogmus, Austin Birmingham, Evan Yee, Juni Anton, Zhengyi Lu, Yuntao Li, Neha Singh, Matthew Morais Johnson, Nazila Loghmani et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
76. Early Molecular Biomarkers in an Amyloid-β-Induced Rat Model of Alzheimer’s Disease: Effects of Kelulut Honey
    Ammara Shaikh, Fairus Ahmad, Jayakumar Murthy, Seong Lin Teoh, Mohamad Fairuz Yahaya · 2026 · International Journal of Molecular Sciences
77. Pretangle tau pathology accrual in the default mode network during the progression of Alzheimer’s disease
    Betul Kara, Ian M. Kelly, John S. Beck, Nathan C. Kuhn, Elliott Jay Mufson, Irving E. Vega, Nicholas M. Kanaan, Scott Counts · 2026 · Molecular Neurodegeneration Advances
78. Blood-based emerging biomarkers in early detection and diagnosis of Alzheimer’s disease
    Trishna Anand, Awanish Kumar · 2026 · International review of neurobiology
79. Long-term exposure to ambient particulate matter and its association with Alzheimer’s disease: influencing factors and a systematic review with meta-analysis
    Na Zhao, Zhenzhen Chen, Hong Sun · 2026 · Frontiers in Public Health
80. Neuroprotective Effects of Herbal Formula Yookgong-Dan on Oxidative Stress-Induced Tau Hyperphosphorylation in Rat Primary Hippocampal Neurons
    Hyunseong Kim, Jin Young Hong, Changhwan Yeo, Hyun Kim, Wan‐Jin Jeon, Junseon Lee, Yoon Jae Lee, In‐Hyuk Ha · 2026 · Biology
81. Post-translational modifications in alzheimer’s disease: proteome dynamics and emerging therapeutic strategies
    Shareen Singh, Amritpal Kaur, Souvik Banerjee, Twinkle Sharma, Takveer Singh · 2026 · Metabolic Brain Disease
82. Recent Alzheimer’s Research Targets Amyloid-β with Novel Phytochemicals and Pharmacological Strategies for Therapy
    Shikha Sharma, Utkarsh Sharma, Neeraj Kumar Sethiya, Lakshit Singh · 2026 · Current Aging Science
83. Machine learning driven identification of shared biomarkers in alzheimer’s disease and diabetic nephropathy: toward dual-disease pathogenesis and diagnosis
    Mengda Liang, Fangfang Yin, Jizhi Tong, Wen Zong, Ningkang Xie, Xutong Shi, Jingjun Yang, Shaowu Lv, Duo Xiao, Juxin Yin · 2026 · Network Modeling Analysis in Health Informatics and Bioinformatics
84. A unique compound 3c targets GSK-3β and metal ion, interferes with tau and metal dyshomeostasis, promotes neurite outgrowth, decreases Aβ accumulation and ABTS•+, and enhances zebrafish motility
    Jing Zhang, Ying Li, Yan-Peng Li, Qingqing Xun, Yuying Ma, Xiao-Long Shi · 2026 · Bioorganic Chemistry
85. From Refractory Epilepsy to Neurodegeneration: Emerging Mechanistic and Clinical Insights Into the Ketogenic Diet
    Chetana G. Ahire, Rajesh Yadav, Utkarsh U. Bhamare, Ginpreet Kaur, Mahesh B. Palkar · 2026 · The FASEB Journal
86. Investigating the Impact of ABCB1 3435C>T (rs1045642) Variant on Severity and Cognitive Decline in Egyptian Alzheimer’s Disease Patients
    Yasmeen Farouk, Nahla Nagy, Azza M. El Amir, Neveen Adel Madbouly, Nashwa Nagy El-Khazragy · 2026 · Molecular Neurobiology
87. Distinct patterns of spontaneous brain activity in mild cognitive impairment patients stratified by cerebrospinal fluid biomarkers
    Wenzhang Qi, Changbao Zhang, Yuchen Feng, Darui Zheng, Yiming Ruan, Qianqian Yuan, Ke Dai, Chen Xue · 2026 · Frontiers in Aging Neuroscience
88. Astrocyte autophagy-pyroptosis crosstalk in Alzheimer’s: insights from knowledge graphs
    Ting Liu, Zhisheng Huang, Hong-Yun Qin · 2026 · BMC Neurology
89. The role of MicroRNAs in Alzheimer’s disease: from pathogenesis to therapeutic potential
    Yingxue Zhou, Shuai Li, Junwu Xiang · 2026 · Molecular Biology Reports
90. Connecting the Dots: Neurobiological Interplay Between Type 2 Diabetes and Alzheimer’s Disease
    Analia Foncea-Bitrán, Cristián Barros-Osorio, Francisca Arriaza, Catalina Ramírez-López, Lina María Ruíz, Marlen Barreto, Fernando C. Ortíz, Francisca Cornejo, Gonzalo I. Gómez · 2026 · International Journal of Molecular Sciences
91. Florzolotau (18F) retention is linked to neuropsychological performance in tauopathy
    Atsushi Shimizu, Yu Iwabuchi, Shogyoku Bun, Memi Watanabe, Masahito Kubota, Sho Shimohama, Toshiki Tezuka, Keisuke Takahata, Hajime Tabuchi, Morinobu Seki et al. · 2026 · Alzheimer s & Dementia
92. Life Cycle and Circadian Rhythms in Central Resident Immunity and Neuropsychiatric Pathology
    Zhixin Lim, Ha Linh Nguyen, Yuanyuan Zeng, Qigngyue Qu, Yan Le, Ming Sun, Xiaoyu Wang, Hong Zhu, Yuchen Qian, Saboor Saeed et al. · 2026 · Neuroscience Bulletin
93. Using β-strand and β-hairpin peptidomimetics induced by constrained amino acids to modulate the aggregation of the microtubule associated protein Tau : design, synthesis and evaluation
    Davide Di Lorenzo · 2023 · theses.fr (ABES)
94. D-sérine : un maillon central de la physiopathologie amyloïde ?
    Eva Ploux · 2022 · theses.fr (ABES)
95. Metabolic Regulatory Networks in Ferroptosis During Alzheimer’s Disease, Mechanisms of Glial Cell Action, and Pathological Correlations with Neuritic Plaques
    Bowen Zhang, Miao Zhang · 2026 · International Journal of General Medicine
96. Mechanisms underlying neuroimmune networks as central regulators in combating neurodegenerative diseases
    Xiangqi Hu, Meng‐Fan Yao, Fenglan Xu, Huajun Wang, Ming Lu, Qiao Chen · 2026 · Neural Regeneration Research
97. Recent Advances in Drug Development for the Management of Alzheimer’s Disease
    Amit Upadhyay, Abhishek Kumar Singh, Nandani Jayaswal, Pooja Jaiswal, S. N. Singh, Shashank Tewari · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
98. Computational strategies for drug discovery in neurodegeneration: Targeting Alzheimer’s and Parkinson’s disease
    Ayoub Ben-Hadda, Fatimazahra Guerguer, Meriem Khedraoui, Imane Yamari, Samir Chtita · 2026 · Letters in Drug Design & Discovery
99. Salidroside mitigates cognitive deficits in AlCl3 exposed aging mouse by modulating APP processing and mitochondrial dysfunction
    Yiru Dong, Huiling Jin, Shengmin Wang, Yanji Xu · 2026 · Frontiers in Behavioral Neuroscience
100. The emerging role of polo-like kinase 2 in Alzheimer's disease
     Laura Martínez-Drudis, Razan Sheta, Dylan Musiol, Maxime Teixeira, Abid Oueslati · 2026 · Experimental Neurology